BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) shot up 2.7% during trading on Friday . The company traded as high as $0.59 and last traded at $0.58. 438,013 shares traded hands during mid-day trading, an increase of 23,462% from the average session volume of 1,859 shares. The stock had previously closed at $0.57.
BriaCell Therapeutics Price Performance
The stock has a market cap of $494,620.40, a price-to-earnings ratio of 0.00 and a beta of 1.09. The firm has a 50 day simple moving average of $0.74 and a two-hundred day simple moving average of $0.80.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Where Do I Find 52-Week Highs and Lows?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to trade using analyst ratings
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Are Penny Stocks a Good Fit for Your Portfolio?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
